CRAMS Industry

  • INR 40000
  • USD 700
Subscribe Now

Annual Review


The chapter explains the happenings in the global pharmaceutical and CRAMS industries. It provides CARE Research's outlook on the domestic CRAMS industry along with the growth rates of its two major segments. It identifies the drivers of, emerging trends in and risks facing the industry. Following points are covered in the chapter-

  • The industry will continue growing in double digits CAGR till FY 2017.
  • Regulating the cost/profit of pharma companies to necessitate outsourcing to the CRAMS industry.
  • Contract manufacturing to remain the dominant segment with ~60% market share of the CRAMS Industry.
  • Contract research segment to outgrow contract manufacturing due to low cost of skilled talent available in India.
  • As an export driven industry, CRAMS growth to be susceptible to external factors.

Impact Analysis

  • CRAMS growth rate moderates, but prospects remains intact…

    With branded drugs worth ~US$105bn going off-patent by FY20, global pharmaceutical companies are expected to enhance their allocations to R&D to incre.....

    + Know More

Healthcare Coverage

Related Reports

Get Alerts

To receive CARE Research publications and alerts.

Register Now >>